NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/15/2024
Back to search
Official data from USPTO
DAEWOONG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
11/15/2024
Trademark type
Word
Nice classes
5, 35
Filing date
04/27/2017
Registration date
11/06/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/15/2024
Last transaction
11/15/2024
Responsible office
United States Patent and Trademark Office
Status code
705
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Seongnam-si, Gyeonggi, KR
Examiner
MMEJE, OBIEZE GINIKANWA
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
DAEWOONG CO., LTD.
Representatives
Bryant E. Wade/Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsacetaminophenacne medicationsacne treatment preparationsadrenal hormone preparationsalcohol for topical useallergy relief medicationsanalgesicsandrogen preparationsanesthetics for surgical and non-surgical useantacidsfungicidesantiarrhythmicsantibioticsanticoagulantsanticonvulsantsantidepressantsantidiabetic preparationsantiviralsanti-cancer preparationsanti-infectivesanti-inflammatoriesantipyretic preparationsantibacterial pharmaceuticalscalcium channel blockersbeta blockersdrug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparationsdrug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparationseye dropseye patches for medical purposeshair growth stimulantsvaccinesadjuvants for use with vaccinesdiureticsamino acids for medical purposes; dietary and nutritional supplements; medicated skin lotions ; bandages for skin wounds; vitamin and mineral preparations for medical use; biological preparations for medical purposes for use in the treatment of the central nervous systemdiabetesskin disorderswoundseye diseases and conditionsswelling in the legsrespiratory diseasesasthmaerectile dysfunctioncardiovascular conditionsheart rhythm disorders and infectious diseases; all-purpose disinfecting preparations; pharmaceutical preparations for use in cardiovascular treatment; diagnostic preparations for medical purposes; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical agents affecting digestive organs; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for treating wounds; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations to prevent swelling in the legs; pharmaceutical preparations for treating respiratory diseases and asthma; pharmaceutical preparations for the treatment of erectile dysfunction; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; plant extracts for pharmaceutical purposes adapted for use in the treatment of the central nervous systemdiabetesskin disorderswoundseye diseases and conditionsswelling in the legsrespiratory diseasesasthmaerectile dysfunctioncardiovascular conditionsheart rhythm disorders and infectious diseases; plant extracts for pharmaceutical purposes adapted for use in chemotherapy; veterinary preparations for treatment of intestinal bacteria in mammals; veterinary vaccines; sanitary preparations for medical use; medical dressings
Class 35
Wholesale and retail store services featuring pharmaceutical and veterinary preparations; wholesale and retail store services featuring dietary supplements; wholesale and retail store services featuring cosmetics; procurement services for others purchasing pharmaceuticals for human and veterinary purposes
Publications
History of USPTO decisions and trademark events.
34 publications found
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/15/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/15/2024
E815
TEAS SECTION 8 & 15 RECEIVED
05/31/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/06/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/06/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/21/2018
PUBO
PUBLISHED FOR OPPOSITION
08/21/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/01/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/16/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/22/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/22/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/21/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/28/2018
GNRT
NON-FINAL ACTION E-MAILED
05/28/2018
CNRT
NON-FINAL ACTION WRITTEN
05/28/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/01/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/01/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/30/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/08/2018
GNSL
LETTER OF SUSPENSION E-MAILED
03/08/2018
CNSL
SUSPENSION LETTER WRITTEN
03/08/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2018
ALIE
ASSIGNED TO LIE
02/01/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/23/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/31/2017
GNRT
NON-FINAL ACTION E-MAILED
07/31/2017
CNRT
NON-FINAL ACTION WRITTEN
07/31/2017
DOCK
ASSIGNED TO EXAMINER
07/25/2017
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/04/2017
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/04/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/03/2017
NWAP
NEW APPLICATION ENTERED
05/01/2017
Continuous trademark protection
Get notified about every new filing that threatens DAEWOONG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.